Initially, GLP-1 drugs were developed and approved to lower blood sugar and A1C levels in patients with type 2 diabetes
Eli Lilly received FDA approval for its tirzepatide-based GLP-1 products, Mounjaro for diabetes and Zepbound for weight loss in May 2022 and November 2023, respectively
This is the comparison most people are already making, so lets address it clearly
Alternate fuel substrates, such as ketones, can support cognitive acute performance improvements [11], while recovering insulin sensitivity and the ability to utilize glucose to meet brain energy demands is critical for long term prevention or slowing cognitive decline
[DOI] [PMC free article] [PubMed] [Google Scholar] 50.Mller TD, Finan B, Bloom SR, D'Alessio D, Drucker DJ, Flatt PR
Well explore: Our personalised assessment process for patients considering or using GLP-1 medications Specific collagen biostimulation protocols tailored to different age groups and weight loss stages Strategic volume replacement techniques to maintain facial harmony Advanced skin quality enhancement treatments Recommended treatment timelines aligned with weight loss phases Conclusion: Knowledge is Prevention Understanding the potential impact of GLP-1 medications on your facial appearance is the first step toward proactive management